FTSE 100 rises as Shell boosts energy stocks despite mining weakness
The UK’s FTSE 100 index edged higher on Tuesday as gains in energy stocks, led by Shell, offset weakness in precious metals miners.
Investing
Business
CZ Says Countries Should Tokenize Stocks and Issue Their…
Binance founder Changpeng Zhao said countries should tokenize their stock markets and issue their own stablecoins, arguing that governments can use blockchain infrastructure
Business
Telegram Wallet Adds Tokenized SK Hynix Shares After $26.5…
Why Are SK Hynix Shares Moving Into Tokenized Markets? Tokenized shares of SK Hynix are now available to users of Wallet in Telegram,
Investing
Rivian stock has flagged an inverted H&S pattern: will the rally continue?
Rivian stock is doing well this month and beating its top rivals like Lucid and Tesla, helped by its strong vehicle delivery numbers.
Business
Polymarket Seeks U.S. License to Offer Margin Trading…
Polymarket is seeking regulatory approval to offer margin trading in the United States, a move that would allow users to take larger event-contract
Investing
Cheap, capable, and controversial: why US companies cannot resist Chinese AI models
Artificial intelligence adoption accelerated sharply across enterprises in 2026, but soaring usage costs are prompting many businesses to rethink their technology choices. This
Business
Binance CEO Says 70% of EU User Withdrawals Moved to…
Binance CEO Richard Teng said about 70% of European user withdrawals following the exchange’s MiCA-related exit moved to self-custodied wallets rather than regulated
Investing
Here’s the key risk facing the Palo Alto Networks stock today
Palo Alto Networks stock continues its strong uptrend this week and is now hovering at its all-time high. PANW jumped by 156% from
Business
JPMorgan Says Private Blockchains Are Bitcoin’s Biggest…
JPMorgan analysts say Bitcoin’s biggest long-term risk may not be Strategy’s massive holdings or near-term selling pressure, but the possibility that traditional finance
Investing
Crinetics stocks surge after Vertex agrees to $10B cash buyout
Crinetics Pharmaceuticals shares surged after Vertex Pharmaceuticals announced an agreement to acquire the endocrinology-focused biotech companyin a deal valued at approximately $10 billion.